Artios Pharma

Description: Artios Pharma develops first-in-class cancer drugs, focusing on DNA Damage Response (DDR) therapies, including ART0380 for solid tumors.

Country: UK

Based in: Cambridge

Founded: 2016

Funding Stage: Series A/B

Tags: ['Biopharma', 'Biotechnology', 'Medical Device']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.